OPKO Health, Inc.
OPK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.28 | 0.13 | -0.00 | 0.53 |
| FCF Yield | -20.44% | -3.92% | -13.32% | 0.20% |
| EV / EBITDA | 8.08 | -20.85 | -3.88 | 37.94 |
| Quality | ||||
| ROIC | -38.34% | -8.67% | -9.46% | 1.81% |
| Gross Margin | 43.61% | 36.84% | 28.70% | 37.90% |
| Cash Conversion Ratio | 3.45 | 0.15 | 0.29 | -1.27 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.78% | -21.35% | -11.23% | 25.31% |
| Free Cash Flow Growth | -368.83% | 62.87% | -2,037.66% | 6.68% |
| Safety | ||||
| Net Debt / EBITDA | 0.54 | -3.52 | -0.56 | 0.64 |
| Interest Coverage | -3.20 | -11.63 | -18.77 | 0.99 |
| Efficiency | ||||
| Inventory Turnover | 7.08 | 8.30 | 9.67 | 12.74 |
| Cash Conversion Cycle | 86.65 | 52.37 | 60.35 | 56.10 |